Guardant Health (GH) Tops Q3 EPS by 21c

Guardant Health (NASDAQ: GH) reported Q3 EPS of ($1.18), $0.21 better than the analyst estimate of ($1.39). Revenue for the quarter came in at $117.4 million versus the consensus estimate of $118.08 million.

For earnings history and earnings-related data on Guardant Health (GH) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Bernstein SocGen Group Reiterates Outperform Rating on Zydus Lifesciences (ZYDUSLIF:IN)
• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg